Evolution of an international external quality assurance model to support laboratory investigation of Streptococcus pneumoniae, developed for the SIREVA project in Latin America, from 1993 to 2005.
In 1993 the Pan American Health Organization initiated a laboratory-based surveillance system, called the SIREVA project, to learn about Streptococcus pneumoniae invasive disease in Latin American children. In 1994, National Laboratories in six countries were trained to perform serotyping and antibiotic susceptibility testing using broth microdilution to determine the MIC for specified antibiotics. An international External Quality Assurance (EQA) program was developed to monitor and support ongoing laboratory performance. The EQA program was coordinated by the National Centre for Streptococcus (NCS), Edmonton, Canada, and included external proficiency testing (EPT) and a validation process requiring regular submission of a sample of isolates from each laboratory to the NCS for verification of the serotype and MIC. In 1999, the EQA program was decentralized to use three of the original laboratories as regional quality control centers to address operational concerns and to accommodate the growth of the laboratory network to more than 20 countries including the Caribbean region. The overall EPT serotyping accuracies for phase I (1993 to 1998) and phase II (1999 to 2005) were 88.0 and 93.8%, respectively; the MIC correlations within +/-1 log(2) dilution of the expected result were 83.0 and 91.0% and the interpretive category agreements were 89.1 and 95.3%. Overall, the validation process serotyping accuracies for phases I and II were 81.9 and 88.1%, respectively, 80.4 and 90.5% for MIC agreement, and 85.8 and 94.3% for category agreement. These results indicate a high level of testing accuracy in participating National Laboratories and a sustained increase in EQA participation in Latin America and the Caribbean.
National Centre for Streptococcus, Rm. 1B3.26 WMC, Provincial Public Health Laboratory, 8440-112 St., Edmonton, T6G 2J2 Alberta, Canada. m.lovgren@provlab.ab.ca
Marguerite
M
Lovgren
James A
JA
Talbot
Maria Cristina
MC
Brandileone
Silvana T
ST
Casagrande
Clara Inés
CI
Agudelo
Elizabeth
E
Castañeda
Mabel
M
Regueira
Alejandra
A
Corso
Ingrid
I
Heitmann
Aurora
A
Maldonado
Gabriela
G
Echániz-Avilés
Araceli
A
Soto-Noguerón
María
M
Hortal
Teresa
T
Camou
Jean-Marc
JM
Gabastou
José Luis
JL
Di Fabio
D006801:Humans; D007753:Laboratories / Q000592:standards; D008826:Microbial Sensitivity Tests / Q000592:standards*; D010068:Oxacillin / Q000494:pharmacology; D011446:Prospective Studies; D011786:Quality Control; D012703:Serotyping / Q000592:standards*; D013296:Streptococcus pneumoniae / Q000145:classification* / Q000187:drug effects*
D010068:Oxacillin